Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M8PM
|
||||
Former ID |
DIB003356
|
||||
Drug Name |
IRX-4
|
||||
Synonyms |
IRX-2 + tumor-specific antigen (cancer), IRx Therapeutics
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Preclinical | [548530] | ||
Company |
IRX Therapeutics Inc
|
||||
Target and Pathway | |||||
Target(s) | Glutamate carboxypeptidase II | Target Info | Immunomodulator (Immunostimulant) | [532510] | |
NetPath Pathway | TCR Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
WikiPathways | One Carbon Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.